Rand Paul misses deadline by 16 months to report wife's COVID 19 treatment stock purchase

about 4 years in USA Today

Gilead Sciences produces remdesivir, an antiviral drug that has been used to treat COVID-19. Kelley Paul invested in Gilead Sciences on Feb. 26, 2020.
      

Mentioned in this news
Share it on